Sterling Investment Advisors (Pennsylvania)’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-400
Closed -$20K 449
2022
Q2
$20K Hold
400
0.01% 328
2022
Q1
$21K Hold
400
0.01% 355
2021
Q4
$20K Hold
400
0.01% 367
2021
Q3
$19K Hold
400
0.01% 363
2021
Q2
$21K Hold
400
0.01% 351
2021
Q1
$20K Hold
400
0.01% 338
2020
Q4
$19K Hold
400
0.01% 311
2020
Q3
$20K Hold
400
0.01% 294
2020
Q2
$20K Hold
400
0.01% 297
2020
Q1
$17K Buy
+400
New +$19.1K 0.01% 284
2018
Q2
Sell
-1,000
Closed -$40K 401
2018
Q1
$40K Hold
1,000
0.02% 219
2017
Q4
$43K Hold
1,000
0.03% 200
2017
Q3
$50K Hold
1,000
0.03% 176
2017
Q2
$48K Hold
1,000
0.03% 182
2017
Q1
$45K Buy
+1,000
New +$42.4K 0.03% 183

Other funds holding SNY

Sterling Investment Advisors (Pennsylvania)'s SNY Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Sanofi (SNY) in Q3 2022, closing a stake of 400 shares — an estimated $20K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in SNY in Q1 2017 and held it in 15 quarters. The position peaked at $50K in Q3 2017. 588 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 400 Sanofi shares in Q3 2022, an estimated $20K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Sanofi in Q1 2017 and held it in 15 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Sanofi position peaked at $50K in Q3 2017.
  • 588 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.